Beijing Scrianen Pharmaceutical Co., Ltd  relies on the strong software and hardware capabilities of the company's R&D center to carry out research and development of new products and technical improvement of old products while producing raw materials; We have an excellent team with rich management experience and exquisite professional skills in pharmaceutical synthesis chemistry, as well as multiple international first-class independent production lines; Equipped with various specifications of synthesis reactors ranging from 50L to 3000L; Committed to providing integrated services such as chemical manufacturing control (CMC), pilot process optimization, and contract manufacturing organization (CMO) for the production and control of chemical drugs and pharmaceutical chemical intermediates for large pharmaceutical companies, small and medium-sized pharmaceutical or biopharmaceutical technology research and development companies both domestically and internationally.

Beijing Scrianen Pharmaceutical Co., Ltd also invested the construction of a active pharmaceutical ingredients (APIs) production research and development base in Lin Gang Economic and Technological Development Zone, Cangzhou, Hebei Province, the national demonstration base for new industrialization, in 2018.The total area is about 280 ares and is divided into two phases of construction. In the first phase, a contract workshop, a lean and compact workshop, a warehouse, Vipshop cards, public utilities, and an office building sewage treatment station have been constructed. In the second phase, a pre-treatment workshop for traditional Chinese medicine extraction and high-tech products will be constructed. At present, raw material drug varieties such as Protamine Sulfate, Promestriene,  Fluorouracil, Trihexyphenidyl Hydrochloride, Ilepcimide, Methotrexate, Chlorquinaldol, Cytarabine Hydrochloride, and Acetazolamide, We have passed GMP certification and been officially produced, and meet the all EP ,USP ,BP ect  international. Pharmacopoeia standard